Back to User profile » Dr David Hollander
Papers published by Dr David Hollander:
Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
Blinder KJ, Dugel PU, Chen S, Jumper JM, Walt JG, Hollander DA, Scott LC
Clinical Ophthalmology 2017, 11:393-401
Published Date: 21 February 2017
The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye
Stonecipher KG, Torkildsen GL, Ousler III GW, Morris S, Villanueva L, Hollander DA
Clinical Ophthalmology 2016, 10:887-895
Published Date: 13 May 2016
Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials
Ciolino JB, McLaurin EB, Marsico NP, Ackerman SL, Williams JM, Villanueva L, Hollander DA
Clinical Ophthalmology 2015, 9:765-772
Published Date: 2 May 2015
Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials
Myers JS, Vold S, Zaman F, Williams JM, Hollander DA
Clinical Ophthalmology 2014, 8:643-652
Published Date: 27 March 2014
Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients
Stonecipher KG, Chia J, Onyenwenyi A, Villanueva L, Hollander DA
Therapeutics and Clinical Risk Management 2013, 9:409-415
Published Date: 25 October 2013
A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model
Ackerman S, D'Ambrosio, Jr F, Greiner JV, Villanueva L, Ciolino JB, Hollander DA
Journal of Asthma and Allergy 2013, 6:43-52
Published Date: 8 April 2013
PERSIST: Physician's Evaluation of Restasis® Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
Mah F, Milner M, Yiu S, Donnenfeld E, Conway TM, Hollander DA
Clinical Ophthalmology 2012, 6:1971-1976
Published Date: 28 November 2012
Evaluation of carboxymethylcellulose 0.5%/glycerin 0.9% and sodium hyaluronate 0.18% artificial tears in patients with mild to moderate dry eye
Roth HW, Conway T, Hollander DA
Clinical Optometry 2011, 3:73-78
Published Date: 25 November 2011
Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
Chang-Lin J-E, Batoosingh AL, Hollander DA, Schiffman RM, Tang-Liu D D-S.
Clinical Ophthalmology 2011, 5:1119-1120
Published Date: 10 August 2011
Demonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacy
Kymes SM, Burk C, Feinman T, Williams JM, Hollander DA
Therapeutics and Clinical Risk Management 2011, 7:283-290
Published Date: 12 July 2011
Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost
Fechtner RD, Harasymowycz P, Nixon DR, Vold SD, Zaman F, Williams JM, Hollander DA
Clinical Ophthalmology 2011, 5:945-953
Published Date: 8 July 2011
Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery
Randall Olson, Eric Donnenfeld, Frank A Bucci Jr, et al
Clinical Ophthalmology 2010, 4:1505-1514
Published Date: 10 December 2010